eMedicine Specialties > Dermatology > Mycobacterial Infections

Papulonecrotic Tuberculids

Author: Robert L Chen, MD, PhD, Instructor, Department of Medicine, Section of Dermatology, University of Chicago Medical Center
Coauthor(s): David Barnette, Jr, MD, Chief of Dermatopathology, Departments of Internal Medicine and Dermatology, Naval Medical Center at San Diego
Contributor Information and Disclosures

Updated: Jan 26, 2007

Introduction

Background

The tuberculids, first described by Darier in 1896, represent a form of cutaneous hypersensitivity reaction to tuberculosis (TB) antigens. Although many types of tuberculids have been described, most are now understood to not be uniquely caused by TB. However, papulonecrotic tuberculids (PNTs) and lichen scrofulosorum are still widely accepted as true tuberculids.

The entity PNT was first established by Pautrier in 1936 as a distinct TB-associated disorder, when he described the characteristic clinical and histopathologic features. PNT is a chronic, recurrent, and symmetric eruption of necrotizing skin papules arising in crops, involving primarily the arms and the legs. A hallmark of this condition is that lesions heal with varioliform scarring. The eruption is believed to represent a hypersensitivity reaction to TB antigens released from a distant focus of infection. Most patients react markedly to the Mantoux skin test (purified protein derivative, PPD) and may exhibit other evidence of current or past TB infection.

Pathophysiology

The pathophysiology of PNT is controversial. Most authors believe this disease entity is triggered by an initial Arthus reaction to mycobacterial antigens. This is then followed by a hypersensitivity reaction in which antigens undergo opsonization by antibodies, followed by immune complex deposition in small cutaneous blood vessels. The ensuing complement cascade triggers a leukocytoclastic vasculitis, leading to destruction of vessel walls with ensuing tissue necrosis. However, other authors dispute this mechanism, citing the lack of leukocytoclastic vasculitis in some cases. Instead, they propose that the primary lesion is the result of subacute lymphohistiocytic vasculitis that leads to thrombosis and subsequent tissue necrosis.

Whatever underlies the pathophysiology, a consensus has been reached that PNT represents a true hypersensitivity reaction rather than the result of a local cutaneous TB infection. This is based on the observation that PNT lesions have consistently failed to either stain positive for, or culture out, mycobacterial organisms. Although the organisms are absent, mycobacterial DNA have been detected in approximately half of the biopsy specimens subjected to polymerase chain reaction. These observations support the idea that lesions of PNT are the result of released mycobacterial antigens in the setting of a concurrent but distant infection.

Frequency

United States

A decreasing incidence of PNT began in the second half of the 1900s and the decline continues to this day. This phenomenon is attributed to aggressive TB control now found in wide practice. Currently, almost all cases come from areas outside of North America with high endemic rates of TB. However, a rare US case, involving a previously healthy 9-year-old girl from Chicago, Ill, was reported in 1990. Historically, reports indicate that young women and children are especially susceptible to this disorder. PNT-like lesions have also been associated with other mycobacterial infections, including Mycobacterium bovis and Mycobacterium kansasii, and from BCG vaccination. With the increased incidence of TB infection in patients with HIV, the frequency of PNT may increase, although this has not yet occurred, due possibly to effective public health measures to identify, isolate, and treat active cases of TB.

International

PNT is an uncommon disorder even in populations with a high prevalence of TB, occurring in less than 5% of active TB cases. In the literature, 91 cases were reported during a 17-year period in South Africa in 1974. In addition, 12 cases from a period of longer than 30 years in England were reported in 1986. In the latter study, most patients were immigrants and had presumably acquired the infection outside of England.

Mortality/Morbidity

The condition typically follows a prolonged and relapsing course lasting years, although spontaneous resolution has been reported. Significant varioliform scarring is a sequela, and progression to lupus vulgaris has been observed. An association with Takayasu arteritis of the aortic arch has also been documented.

Sex

Females seem to be at a slightly increased risk for developing this disorder.

Age

Children and young adults are more susceptible to this condition than other people. In the 1974 study from South Africa, two thirds of the patients were younger than 30 years.

Clinical

History

  • The characteristic lesions are small, erythematous, inflammatory papules that undergo central ulceration and heal spontaneously within weeks, leaving a varioliform scar.
  • Lesions arise in symmetric crops, typically with an acral predilection. Characteristically, lesions develop over the extensor surfaces, particularly the knees, the elbows, and the dorsum of the hands and the feet, although widespread involvement may be present.
  • New lesions form as older lesions resolve, giving the eruption a polymorphous appearance.
  • Oral lesions have not been reported to date.
  • PNTs have been reported to coexist with lesions of erythema induratum, as well as lichen scrofulosorum. In several reports, cutaneous lesions resolved with appropriate anti-TB therapy.

Physical

  • Primary lesion: The characteristic initial lesions are 2- to 8-mm, erythematous papules that become pustules and undergo central ulceration forming hemorrhagic-crusted papules.
  • Distribution: Lesions arise in symmetric crops, typically with an acral predilection. Characteristically, lesions develop over the extensor surfaces, particularly the knees, the elbows, and the dorsum of the hands and the feet, although widespread involvement may occur. Involvement of the glans penis has also been reported.
  • Color: Hyperpigmented to erythematous papules with central crusting are seen early, and the lesions generally heal with scarring.
  • Lymph nodes: In one study, as many as one third of the cases were associated with cervical lymphadenopathy, and some patients developed scrofuloderma.

Causes

The eruption is a form of an exaggerated host immunologic response to a mycobacterial infection involving the cutaneous vessels. Active TB is reported in as many as 40% of patients.

More on Papulonecrotic Tuberculids

Overview: Papulonecrotic Tuberculids
Differential Diagnoses & Workup: Papulonecrotic Tuberculids
Treatment & Medication: Papulonecrotic Tuberculids
Follow-up: Papulonecrotic Tuberculids
Multimedia: Papulonecrotic Tuberculids
References

References

  1. Barbagallo J, Tager P, Ingleton R, et al. Cutaneous tuberculosis: diagnosis and treatment. Am J Clin Dermatol. 2002;3(5):319-28. [Medline].

  2. Chalermdamrichai P, Puavilai S, Jerasutus S, et al. Sarcoidosis presenting as papulonecrotic tuberculid-like lesions: report of a case. J Med Assoc Thai. Jul 2004;87(7):839-44. [Medline].

  3. Darier MJ. Des "tuberculides" cutanees. Ann Dermatol Syph. 1896;7:1431-36.

  4. Fernandes C, Maltez F, Lourenço S, et al. Papulonecrotic tuberculid in a human immunodeficiency virus type-1 patient with multidrug-resistant tuberculosis. J Eur Acad Dermatol Venereol. May 2004;18(3):369-70. [Medline].

  5. Freiman A, Ting P, Miller M, Greenaway C. Papulonecrotic tuberculid: a rare form of cutaneous tuberculosis. Cutis. Jun 2005;75(6):341-6. [Medline].

  6. Iden DL, Rogers RS 3rd, Schroeter AL. Papulonecrotic tuberculid secondary to Mycobacterium bovis. Arch Dermatol. Apr 1978;114(4):564-6. [Medline].

  7. Jordaan HF, Van Niekerk DJ, Louw M. Papulonecrotic tuberculid. A clinical, histopathological, and immunohistochemical study of 15 patients. Am J Dermatopathol. Oct 1994;16(5):474-85. [Medline].

  8. Milligan A, Chen K, Graham-Brown RA. Two tuberculides in one patient--a case report of papulonecrotic tuberculide and erythema induratum occurring together. Clin Exp Dermatol. Jan 1990;15(1):21-3. [Medline].

  9. Morrison JG, Fourie ED. The papulonecrotic tuberculide. From Arthus reaction to lupus vulgaris. Br J Dermatol. Sep 1974;91(3):263-70. [Medline].

  10. Pautrier L-M. Tuberculose nodulare dermique á petits nodules. In: Darier J, ed. Nouvelle Pratique. Paris: Masson Editeur. 1936.

  11. Senol M, Ozcan A, Aydin A, et al. Disseminated lupus vulgaris and papulonecrotic tuberculid: case report. Pediatr Dermatol. Mar-Apr 2000;17(2):133-5. [Medline].

  12. Sloan JB, Medenica M. Papulonecrotic tuberculid in a 9-year-old American girl: case report andreview of the literature. Pediatr Dermatol. Sep 1990;7(3):191-5. [Medline].

  13. Thappa DM, Karthikeyan K, Jayanthi S. Tuberculid in a child: transformation from papulonecrotic to lichen scrofulosorum. Pediatr Dermatol. Jan-Feb 2003;20(1):91-3. [Medline].

  14. Victor T, Jordaan HF, Van Niekerk DJ, et al. Papulonecrotic tuberculid. Identification of Mycobacterium tuberculosisDNA by polymerase chain reaction. Am J Dermatopathol. Dec 1992;14(6):491-5. [Medline].

  15. Wilson-Jones E, Winkelmann RK. Papulonecrotic tuberculid: a neglected disease in Western countries. J Am Acad Dermatol. May 1986;14(5 Pt 1):815-26. [Medline].

Further Reading

Keywords

PNT, necrotizing skin papules, tuberculosis hypersensitivity, TB antigens

Contributor Information and Disclosures

Author

Robert L Chen, MD, PhD, Instructor, Department of Medicine, Section of Dermatology, University of Chicago Medical Center
Robert L Chen, MD, PhD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, Dermatology Foundation, and Society for Investigative Dermatology
Disclosure: Nothing to disclose.

Coauthor(s)

David Barnette, Jr, MD, Chief of Dermatopathology, Departments of Internal Medicine and Dermatology, Naval Medical Center at San Diego
David Barnette, Jr, MD is a member of the following medical societies: American Academy of Dermatology and American Society of Dermatopathology
Disclosure: Nothing to disclose.

Medical Editor

Terry L Barrett, MD, Director, Associate Professor, Department of Dermatology, Division of Dermatopathology and Oral Pathology, Johns Hopkins University School of Medicine
Terry L Barrett, MD is a member of the following medical societies: American Academy of Dermatology, American Medical Association, American Society of Dermatopathology, College of American Pathologists, and United States and Canadian Academy of Pathology
Disclosure: Nothing to disclose.

Pharmacy Editor

Michael J Wells, MD, Associate Professor, Department of Dermatology, Texas Tech University Health Sciences Center
Michael J Wells, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, and Texas Medical Association
Disclosure: Nothing to disclose.

Managing Editor

Lester F Libow, MD, Dermatopathologist, South Texas Dermatopathology Laboratory
Lester F Libow, MD is a member of the following medical societies: American Academy of Dermatology, American Society of Dermatopathology, European Academy of Dermatology and Venereology, International Society of Dermatology, Massachusetts Medical Society, New York Academy of Sciences, Phi Beta Kappa, Society for Investigative Dermatology, and Texas Medical Association
Disclosure: Nothing to disclose.

CME Editor

Joel M Gelfand, MD, MSCE, Medical Director, Clinical Studies Unit, Assistant Professor, Department of Dermatology, Associate Scholar, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania
Joel M Gelfand, MD, MSCE is a member of the following medical societies: Society for Investigative Dermatology
Disclosure: AMGEN Consulting fee Consulting; AMGEN Grant/research funds None; Genentech Consulting fee Consulting; Centocor Consulting fee Consulting; Centocor Grant/research funds None; Covance Consulting fee Consulting; Shire  Consulting

Chief Editor

William D James, MD, Paul R Gross Professor of Dermatology, University of Pennsylvania School of Medicine; Vice-Chair, Program Director, Department of Dermatology, University of Pennsylvania Health System
William D James, MD is a member of the following medical societies: American Academy of Dermatology and Society for Investigative Dermatology
Disclosure: elsevier Royalty Other; american college of physicians Honoraria Other

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.